Brief Research Report
Accepted on 31 Jul 2025
Identification of a novel PRMD16::SKI fusion gene in T-prolymphocytic Leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1658257
Type at least 3 characters
1,890 articles
Review
Accepted on 30 Jul 2025
TP53-Mutated MDS and AML: Immune Dysregulation, Tumor Microenvironment, and Emerging Therapeutic Strategies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1655486
- 129 views
Case Report
Accepted on 30 Jul 2025
Successful Remission Induction Therapy with Azacitidine and Venetoclax for a Treatment-Naive Elderly Patient with ETP/Myeloid Mixed-Phenotype Acute Leukemia: A Case Report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1628767
- 128 views
Original Research
Accepted on 30 Jul 2025
Machine Learning-Based Nomogram Predicts Heart Failure Risk in Elderly Relapsed/Refractory Multiple Myeloma Patients Receiving Carfilzomib-Based Therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1624680
- 156 views
Original Research
Published on 30 Jul 2025
Identification and visualization of fusion gene subtypes in APL using spatial attention mechanisms in vision models
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1619296
- 418 views
Perspective
Published on 30 Jul 2025
A roadmap to implementing outpatient administration of bispecific antibodies in multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1630146
- 806 views
Systematic Review
Accepted on 29 Jul 2025
CD20×CD3 bispecific antibody achieved significant efficacy in patients with large B-cell lymphoma relapsing after or refractory to CAR-T therapy: a systematic review and meta-analysis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1641769
- 138 views
Review
Published on 29 Jul 2025
Nestin in multiple myeloma: emerging insights into a potential therapeutic target
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1596928
- 292 views
Case Report
Published on 29 Jul 2025
Case Report: A familial hematological pedigree reveals VHL germline mutation as a principal predisposition factor with additional mutations modulating phenotypic heterogeneity
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1630715
- 279 views
Case Report
Accepted on 28 Jul 2025
Diagnosis of Splenic Marginal Zone Lymphoma by Ultrasound and Contrast-Enhanced Ultrasound: A Case Report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1569962
- 112 views
Case Report
Accepted on 28 Jul 2025
Novel e4a2 BCR∷ABL1 Transcript with Insertion of CSE1L Exons 9 and 10 in a CML Patient: a Case Report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1596256
Original Research
Published on 28 Jul 2025
Disproportionality analysis of adverse events associated with pacritinib: a real-world study based on FDA Adverse Event Reporting System (FAERS) database
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1618267
- 369 views
Original Research
Accepted on 25 Jul 2025
Development and Validation of a Machine Learning-Based Early Warning System for Predicting Venous Thromboembolism Risk in Hospitalized Lymphoma Patients Undergoing Chemotherapy: a multicentre and retrospective cohort study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1566905
- 268 views
Case Report
Accepted on 25 Jul 2025
Obinutuzumab Combined with Bendamustine for the Treatment of Hairy Cell Leukemia Variant: A Case Report and Literature Review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1635856
- 168 views
Original Research
Published on 25 Jul 2025
NAP1L5 in acute myeloid leukemia: a prognostic biomarker and potential therapeutic target
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1617564
- 410 views
Mini Review
Published on 25 Jul 2025
Philadelphia chromosome-positive mixed-phenotype acute leukemia: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1623528
- 531 views